Support The Moscow Times!
Contribute today

Chinese Firm to Make 60M Doses of Russia's Sputnik Vaccine

By AFP
Sputnik V has been registered in 57 countries with a combined population of more than 1.5 billion people. Olga Maltseva / AFP

Russia has agreed a deal for more than 60 million doses of its Sputnik V vaccine to be produced in China from May, the jab's developer said on Monday.

The Russian Direct Investment Fund (RDIF), which has financed the development of the vaccine, said it and Shenzhen Yuanxing Gene-tech Co. "have agreed to cooperate on production of over 60 million doses" of Sputnik in China.

The RDIF, Russia's sovereign wealth fund that has backed the development of the vaccine, said that the amount of the two-dose vaccine would be enough to vaccinate some 30 million people, adding that production would begin in May.

"Cooperation with Shenzhen Yuanxing Gene-tech will enable us to produce Sputnik V in China, thus increasing the capacities to provide additional amounts as we see rising demand for the Russian vaccine globally," CEO Kirill Dmitriev said in a statement.

The West has accused Beijing and Moscow of using their vaccines as tools to win geopolitical clout.

Russia and China have rejected claims that they are seeking to use coronavirus vaccines to project their influence and accused Western countries of hoarding vaccines to the detriment of poor nations.

The Sputnik V vaccine has been registered in 57 countries, with a total population of more than 1.5 billion people.

Read more about: Sputnik V , China , Vaccine

Sign up for our free weekly newsletter

Our weekly newsletter contains a hand-picked selection of news, features, analysis and more from The Moscow Times. You will receive it in your mailbox every Friday. Never miss the latest news from Russia. Preview
Subscribers agree to the Privacy Policy

A Message from The Moscow Times:

Dear readers,

We are facing unprecedented challenges. Russia's Prosecutor General's Office has designated The Moscow Times as an "undesirable" organization, criminalizing our work and putting our staff at risk of prosecution. This follows our earlier unjust labeling as a "foreign agent."

These actions are direct attempts to silence independent journalism in Russia. The authorities claim our work "discredits the decisions of the Russian leadership." We see things differently: we strive to provide accurate, unbiased reporting on Russia.

We, the journalists of The Moscow Times, refuse to be silenced. But to continue our work, we need your help.

Your support, no matter how small, makes a world of difference. If you can, please support us monthly starting from just $2. It's quick to set up, and every contribution makes a significant impact.

By supporting The Moscow Times, you're defending open, independent journalism in the face of repression. Thank you for standing with us.

Once
Monthly
Annual
Continue
paiment methods
Not ready to support today?
Remind me later.

Read more

Iran, Ghana Among Those Hit Hardest By Russia’s Vaccine Delivery Delays – BBC

Russia has touted Sputnik V as a cheap, easy to transport way out of the pandemic but its exports have hit snags.

EU Approval of Russia’s Sputnik V Vaccine Faces More Delays Over 'Incomplete' Data – Reuters

The vaccine's developers are “not used to working with a regulatory agency like the EMA,” a source close to the EU regulator said.

In EU First, Italian Factory to Produce Russia’s Sputnik V Vaccine

Similar talks are underway in France and Germany despite the vaccine not yet being approved for use within the 27-member bloc.

Russia Says It Has Vaccinated 1.5M. Some Experts Think the Numbers Don’t Add Up.

Official coronavirus statistics have been controversial since the start of the pandemic. Now, the Sputnik V rollout is under the spotlight.